Class information for:
Level 1: AZALINE B//ANTIOVULATORY ACTIVITY//LHRH ANTAGONISTS

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
9482 1083 27.5 50%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
2982 2124 ENDOCRINE POLYPEPTIDE CANC//LHRH RECEPTOR//SECT EXPT MED

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 AZALINE B Author keyword 6 80% 0% 4
2 ANTIOVULATORY ACTIVITY Author keyword 4 56% 0% 5
3 LHRH ANTAGONISTS Author keyword 4 41% 1% 7
4 LH RH ANTAGONIST Author keyword 3 37% 1% 7
5 HORMONE SENSITIVE CANCERS Author keyword 2 67% 0% 2
6 ANIM SCI PROD GRP Address 2 33% 0% 5
7 BETIDAMINO ACIDS Author keyword 1 100% 0% 2
8 DMBA MAMMARY CARCINOMA Author keyword 1 100% 0% 2
9 WOMENS HOSP MAX PLANCK CLIN UNIT REPROD MED Address 1 100% 0% 2
10 LHRH ANTAGONIST Author keyword 1 19% 1% 6

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 AZALINE B 6 80% 0% 4 Search AZALINE+B Search AZALINE+B
2 ANTIOVULATORY ACTIVITY 4 56% 0% 5 Search ANTIOVULATORY+ACTIVITY Search ANTIOVULATORY+ACTIVITY
3 LHRH ANTAGONISTS 4 41% 1% 7 Search LHRH+ANTAGONISTS Search LHRH+ANTAGONISTS
4 LH RH ANTAGONIST 3 37% 1% 7 Search LH+RH+ANTAGONIST Search LH+RH+ANTAGONIST
5 HORMONE SENSITIVE CANCERS 2 67% 0% 2 Search HORMONE+SENSITIVE+CANCERS Search HORMONE+SENSITIVE+CANCERS
6 BETIDAMINO ACIDS 1 100% 0% 2 Search BETIDAMINO+ACIDS Search BETIDAMINO+ACIDS
7 DMBA MAMMARY CARCINOMA 1 100% 0% 2 Search DMBA+MAMMARY+CARCINOMA Search DMBA+MAMMARY+CARCINOMA
8 LHRH ANTAGONIST 1 19% 1% 6 Search LHRH+ANTAGONIST Search LHRH+ANTAGONIST
9 DESLORELIN 1 11% 1% 9 Search DESLORELIN Search DESLORELIN
10 CARDIOMYOCYTE SHORTENING 1 50% 0% 1 Search CARDIOMYOCYTE+SHORTENING Search CARDIOMYOCYTE+SHORTENING

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ANTIDE 18 83% 1% 10
2 PROLONGED DURATION 8 60% 1% 9
3 GONADOTROPIN INHIBITION 6 80% 0% 4
4 LYS GNRH ANTAGONIST 6 100% 0% 4
5 OMEGA CYANOGUANIDINO MOIETIES 6 100% 0% 4
6 CONSTANT INFUSION 5 30% 1% 14
7 AZALINE B 3 100% 0% 3
8 LHRH ANTAGONIST 3 28% 1% 10
9 CONFORMATION FUNCTION RELATIONSHIPS 3 45% 0% 5
10 HORMONE ANTAGONISTS 2 24% 1% 8

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
GONADOTROPIN-RELEASING-HORMONE ANALOG DESIGN - STRUCTURE-FUNCTION STUDIES TOWARD THE DEVELOPMENT OF AGONISTS AND ANTAGONISTS - RATIONALE AND PERSPECTIVE 1986 412 64 63%
NAFARELIN - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND CLINICAL POTENTIAL IN SEX HORMONE-RELATED CONDITIONS 1990 36 51 51%
Rational use of agonists and antagonists of luteinizing hormone-releasing hormone (LH-RH) in the treatment of hormone-sensitive neoplasms and gynaecologic conditions 1997 14 74 35%
Chemistry and molecular biology in the search for new LHRH antagonists 1997 10 85 44%
GNRH AGONISTS AND ANTAGONISTS - CURRENT CLINICAL STATUS 1988 71 102 36%
COMPARISON OF THE POTENTIAL FOR THERAPEUTIC UTILITIES WITH GONADOTROPIN-RELEASING-HORMONE AGONISTS AND ANTAGONISTS 1986 97 89 57%
BUSERELIN - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND CLINICAL PROFILE 1990 37 125 40%
DESIGN OF BIOLOGICALLY-ACTIVE, CONFORMATIONALLY CONSTRAINED GNRH ANTAGONISTS 1990 33 10 40%
THE STRUCTURAL FEATURES OF EFFECTIVE ANTAGONISTS OF THE LUTEINIZING-HORMONE-RELEASING HORMONE 1994 3 22 73%
GOSERELIN - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND CLINICAL USE IN SEX-HORMONE RELATED CONDITIONS 1991 26 79 30%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 ANIM SCI PROD GRP 2 33% 0.5% 5
2 WOMENS HOSP MAX PLANCK CLIN UNIT REPROD MED 1 100% 0.2% 2
3 DRUG PREFORMULAT DELIVERY 1 50% 0.1% 1
4 GEN ATOM COURT 1 50% 0.1% 1
5 HARTER VET MED 1 50% 0.1% 1
6 MED MED POPULAT REPROD 1 50% 0.1% 1
7 MED MED SECT EXPT MED 1 50% 0.1% 1
8 VET ADM MED MED MED 1 50% 0.1% 1
9 WALLACE ANIM 1 50% 0.1% 1
10 WOMENS HOSP EXPTL ENDOCRINOL 1 50% 0.1% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000279683 LHRH RECEPTOR//AN 152//ENDOCRINE POLYPEPTIDE CANC
2 0.0000167530 MALE CONTRACEPTION//VAS OCCLUSION//MALE HORMONAL CONTRACEPTION
3 0.0000163646 EXPLORATORY DISCOVERY//CYCLIC IMINES//3 ACYLLACTAMS
4 0.0000148714 ANDROGEN DEPRIVATION THERAPY//INTERMITTENT ANDROGEN SUPPRESSION//BICALUTAMIDE
5 0.0000145257 LIVINGSTON REPROD BIOL//HLTH SCI GYNECOL OBSTET//LUTEINIZATION STIMULATOR
6 0.0000106902 CENTRAL PRECOCIOUS PUBERTY//PRECOCIOUS PUBERTY//PREMATURE THELARCHE
7 0.0000101200 LEYDIG CELLS//LEYDIG CELL//TESTICULAR CAPSULOTOMY
8 0.0000099246 OSTEOBLASTIC METASTASIS//3 D COLLAGEN//AHTO 7
9 0.0000098491 HYPOTHALAMIC AMENORRHEA//PULSATILE GNRH//INTERDISCIPLINARY BIOPHYS PROGRAM
10 0.0000094860 GONADOTROPE//GNRH RECEPTOR//FUNCT GENOM S